SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001654954-19-001523
Filing Date
2019-02-14
Accepted
2019-02-14 10:14:04
Documents
2

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT camberatra-a201813g.htm SC 13G/A 62589
2 JOINT FILING AGREEMENT atra-a13g2018ex1filed.htm EX-1 4971
  Complete submission text file 0001654954-19-001523.txt   69230
Mailing Address 101 HUNTINGTON AVENUE SUITE 2101 BOSTON MA 02199
Business Address 101 HUNTINGTON AVENUE SUITE 2101 BOSTON MA 02199 617-717-6600
Camber Capital Management LP (Filed by) CIK: 0001444043 (see all company filings)

IRS No.: 421693587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Subject) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88393 | Film No.: 19602015
SIC: 2836 Biological Products, (No Diagnostic Substances)